SCHEMBL120044

SCHEMBL120044

C/N=N\N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4460268 1.00
SCHEMBL120045 1.00
Ethane SCHEMBL8500378 0.94
SCHEMBL8498997 0.82
SCHEMBL192490 0.72
SCHEMBL14885565 0.71
SCHEMBL15756157 0.69
SCHEMBL16490926 0.69
SCHEMBL16204763 0.69
SCHEMBL18289536 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4608801-A1 ANTICANCER DRUG CONJUGATES Ariel Scientific Innovations Ltd. (IL) 2025-09-03 EP disclosed
US-12338244-B2 Temozolomide compounds, polymers prepared therefrom, and method of treating a disease UNIVERSITY OF MASSACHUSETTS (US) 2025-06-24 US disclosed
US-20240254127-A1 TEMOZOLOMIDE COMPOUNDS, POLYMERS PREPARED THEREFROM, AND METHOD OF TREATING A DISEASE UNIVERSITY OF MASSACHUSETTS 2024-08-01 US disclosed
WO-2024089683-A1 ANTICANCER DRUG CONJUGATES Ariel Scientific Innovations Ltd. (IL) 2024-05-02 WO disclosed
US-11912709-B2 Temozolomide compounds, polymers prepared therefrom, and method of treating a disease UNIVERSITY OF MASSACHUSETTS (US) 2024-02-27 US disclosed
EP-3894397-A1 THERAPEUTIC CONJUGATES Ariel Scientific Innovations Ltd. (IL) 2021-10-20 EP disclosed
US-20210299260-A1 THERAPEUTIC CONJUGATES Ariel Scientific Innovations Ltd. (IL) 2021-09-30 US disclosed
US-20210198265-A1 TEMOZOLOMIDE COMPOUNDS, POLYMERS PREPARED THEREFROM, AND METHOD OF TREATING A DISEASE UNIVERSITY OF MASSACHUSETTS 2021-07-01 US disclosed
US-10995094-B2 Temozolomide compounds, polymers prepared therefrom, and method of treating a disease THE UNIVERSITY OF MASSACHUSETTS (US) 2021-05-04 US disclosed
WO-2020240199-A1 THERAPEUTIC COMPOUNDS THE UNIVERSITY OF NOTTINGHAM (GB) 2020-12-03 WO disclosed
US-20100068178-A1 ANTI-CANCER DRUGS AND USES RELATING THERETO FOR METASTATIC MALIGNANT MELANOMA AND OTHER CANCERS LAILA NUTRACEUTICALS (IN) 2010-03-18 US disclosed
WO-2010029577-A2 ANTI-CANCER DRUGS AND USES RELATING THERETO FOR METASTATIC MALIGNANT MELANOMA AND OTHER CANCERS GOKARAJU GANGA RAJU (IN) 2010-03-18 WO disclosed
US-7572798-B2 Prevent Dna damage; antitumor, anticancer agents; blocking epidermal growth factor receptor MCGILL UNIVERSITY (CA) 2009-08-11 US disclosed
WO-2009077741-A2 3-SUBSTITUTED-4-OXO-3,4-DIHYDRO-IMIDAZO-[5,1-D][1,2,3,5-TETRAZINE-8-CARBOXYLIC ACID AMIDES AND THEIR USE PHARMINOX LIMITED (GB) 2009-06-25 WO disclosed
US-7517998-B2 Benzothiazole or benzothiazine derivative of dipyrido(2,3;b:2',3'-e) diazepin-6-one; viricide against human t-cell leukemia/lymphoma virus BOEHRINGER INGELHEIM INTERNATIONAL GMBH 2009-04-14 US disclosed
US-7276576-B1 Mammalian ICYP (iodocyanopindolol) receptor and its applications DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-10-02 US disclosed
EP-1366027-B1 COMBI-MOLECULES HAVING SIGNAL TRANSDUCTION INHIBITORY PROPERTIES AND DNA DAMAGING PROPERTIES UNIV MCGILL (CA) 2006-09-20 EP disclosed
US-20040086907-A1 Combi-molecules having signal transduction inhibitory properties and dna damaging properties QIU, QIYU 2004-05-06 US disclosed
EP-1366027-A1 COMBI-MOLECULES HAVING SIGNAL TRANSDUCTION INHIBITORY PROPERTIES AND DNA DAMAGING PROPERTIES McGILL UNIVERSITY (CA) 2003-12-03 EP disclosed
WO-2002068396-A1 COMBI-MOLECULES HAVING SIGNAL TRANSDUCTION INHIBITORY PROPERTIES AND DNA DAMAGING PROPERTIES MCGILL UNIVERSITY (CA) 2002-09-06 WO disclosed